264
Views
12
CrossRef citations to date
0
Altmetric
Special Report

Allergic contact dermatitis caused by topical antiacne drugs

, &

References

  • Heel RC, Brogden RN, Speight TM, et al. Vitamin A acid: a review of its pharmacological properties and therapeutic use in the topical treatment of acne vulgaris. Drugs 1977;14:401-19
  • Veraldi S, Schianchi R. Short contact therapy of acne with tretinoin. Eur J Acne 2011;2(Suppl 1):1-2
  • Veraldi S, Barbareschi M, Benardon S, et al. Short contact therapy of acne with tretinoin. J Dermatol Treat 2013;24:374-6
  • Cunliffe WJ, Gollnick HP. Topical therapy. In: Acne. Diagnosis and management. Martin Dunitz; London: 2001. p. 107-14
  • Watkins SA, Maibach HI. The hardening phenomenon in irritant contact dermatitis: an interpretative update. Contact Dermat 2009;60:123-30
  • Jordan WPJr, Higgins M, Dvorak J. Allergic contact dermatitis to all-trans-retinoic acid; epicutaneous and leukocyte migration inhibition testing. Contact Dermat 1975;1:306-10
  • Lindgren S, Groth O, Molin L. Allergic contact response to vitamin A acid. Contact Dermat 1976;2:212-17
  • Nordqvist BC, Mehr K. Allergic contact dermatitis to retinoic acid. Contact Dermat 1977;3:55-6
  • Rudzki E, Grzywa Z. Dermatitis from retinoic acid. Contact Dermat 1978;4:305-6
  • Romaguera C, Grimalt F. Sensitization to benzoyl peroxide, retinoic acid and carbon tetrachloride. Contact Dermat 1980;6:442
  • Blondeel A. Contact allergy to vitamin A. Contact Dermat 1984;11:191-2
  • Tosti A, Guerra L, Morelli R, et al. Contact dermatitis due to topical retinoic acid. Contact Dermat 1992;26:276-7
  • Tomb R, Dolfus A, Couppie P. Eczéma par allergie de contact à la trétinoïne. Ann Dermatol Venereol 1992;119:761-4
  • Manzano D, Aguirre A, Gardeazabal J, et al. Allergic contact dermatitis from tocopheryl acetate (vitamin E) and retinol palmitate (vitamin A) in a moisturizing cream. Contact Dermat 1994;31:324
  • Balato N, Patruno C, Lembo G, et al. Allergic contact dermatitis from retinoic acid. Contact Dermat 1995;32:51
  • Balato N. Allergic contact dermatitis from retinoic acid? Contact Dermatitis 1995;33:142
  • Heidenheim M, Jemec GB. Occupational allergic contact dermatitis from vitamin A acetate. Contact Dermat 1995;33:439
  • Balato N, Lembo G, Cuccurullo FM, et al. Acne and allergic contact dermatitis. Contact Dermat 1996;34:68-9
  • Bazzano C, de Angeles S, Kleist G, et al. Allergic contact dermatitis from topical vitamins A and E. Contact Dermat 1996;35:261-2
  • Clemmensen A, Thormann J, Andersen KE. Allergic contact dermatitis from retinyl palmitate in polycaprolactone. Contact Dermat 2007;56:288-9
  • Anderson A, Gebauer K. Periorbital allergic contact dermatitis resulting from topical retinoic acid use. Australas J Dermatol 2014;55:152-3
  • Berg JE, Bowman JP, Saenz AB. Cumulative irritation potential and contact sensitization potential of tazarotene foam 0.1% in 2 phase 1 patch studies. Cutis 2012;90:206-11
  • Serup J. Allergic contact dermatitis from retinoic acid? Contact Dermat 1995;33:142
  • Slade HB, Shroot B, Feldman SR, et al. Reappraising the phototoxicity of tretinoin: a report of four controlled clinical trials. Photodermatol Photoimmunol Photomed 2009;25:146-52
  • Hogan DJ, Saenz AB. Phototoxic and photoallergic potential of tazarotene foam 0.1% in 2 phase 1 patch studies. Cutis 2012;90:266-71
  • Eaglstein WH. Allergic contact dermatitis to benzoyl peroxide. Report of cases. Arch Dermatol 1968;97:527
  • Lindemayr H, Drobil M. Contact sensitization to benzoyl peroxide. Contact Dermat 1981;7:137-40
  • Cunliffe WJ, Burke B. Benzoyl peroxide: lack of sensitization. Acta Derm Venereol 1982;62:458-9
  • Haustein UF, Tegetmeyer L, Ziegler V. Allergic and irritant potential of benzoyl peroxide. Contact Dermat 1985;13:252-7
  • Sevila A, Romaguera C, Vilaplana J, et al. Contact dermatitis in children. Contact Dermat 1994;30:292-4
  • Akhavan A, Bershad S. Topical acne drugs. Review of clinical properties, systemic exposure, and safety. Am J Clin Dermatol 2003;4:473-92
  • Shwereb C, Lowenstein EJ. Delayed type hypersensitivity to benzoyl peroxide. J Drugs Dermatol 2004;3:197-9
  • Bulinckx A, Dachelet C, Leroy A, et al. Contact dermatitis to the combination gel of adapalene 0.1% and benzoyl peroxide (PBO) 2.5%. Eur J Dermatol 2012;22:139-40
  • Felton SJ, Orton D, Williams JD. Benzoyl peroxide in topical acne preparations: an underreported contact allergen? Dermatitis 2013;24:146-7
  • Tkach JR. Allergic contact urticaria to benzoyl peroxide. Cutis 1982;29:187-8
  • Minciullo PL, Patafi M, Giannetto L, et al. Allergic contact angioedema to benzoyl peroxide. J Clin Pharm Ther 2006;31:385-7
  • Coskey RJ. Contact dermatitis due to clindamycin. Arch Dermatol 1978;114:446
  • Herstoff JK. Sensitization to topical antibiotics. Arch Dermatol 1978;114:1402
  • de Groot AC. Contact allergy to clindamycin. Contact Dermat 1982;8:428
  • Conde-Salazar L, Guimaraens D, Romero LV. Contact dermatitis from clindamycin. Contact Dermat 1983;9:225
  • de Kort WJ, de Groot AC. Clindamycin allergy presenting as rosacea. Contact Dermat 1989;20:72-3
  • Yokoyama R, Mizuno E, Takeuchi M, et al. Contact dermatitis due to clindamycin. Contact Dermat 1991;25:125
  • Vejlstrup E, Menné T. Contact dermatitis from clindamycin. Contact Dermat 1995;32:110
  • Muñoz D, Del Pozo MD, Audícana M, et al. Erythema-multiforme-like eruption from antibiotics of 3 different groups. Contact Dermat 1996;34:227-8
  • García R, Galindo PA, Feo F, et al. Delayed allergic reactions to amoxycillin and clindamycin. Contact Dermat 1996;35:116-17
  • Kircik LH, Peredo MI, Bucko AD, et al. Safety of a novel gel formulation of clindamycin phosphate 1.2%-tretinoin 0.025%: results from a 52-week open-label study. Cutis 2008;82:358-66
  • Murray J, Potts A. The phototoxic and photoallergy potential of clindamycin phosphate 1.2%/tretinoin 0.025% gel for facial acne: results of two single-center, evaluator-blinded, randomized, vehicle-controlled phase 1 studies in healthy volunteers. J Drugs Dermatol 2014;13:16-22
  • Fisher AA. The safety of topical erythromycin. Contact Dermat 1976;2:43-4
  • van Ketel WG. Immediate- and delayed-type allergy to erythromycin. Contact Dermat 1976;2:363-4
  • Lombardi P, Campolmo P, Spallanzani P, et al. Delayed hypersensitivity to erythromycin. Contact Dermat 1982;8:416
  • Fisher AA. Is topical erythromycin base non-allergenic? Contact Dermat 1983;9:243
  • Fernandez Redondo V, Casas L, Taboada M, et al. Systemic contact dermatitis from erythromycin. Contact Dermat 1994;30:43-4
  • Fernandez Redondo V, Casas L, Taboada M, et al. Systemic contact dermatitis from erythromycin. Contact Dermat 1994;30:311
  • Martins C, Freitas JD, Gonçalo M, et al. Allergic contact dermatitis from erythromycin. Contact Dermat 1995;33:360
  • Valsecchi R, Pansera B, Reseghetti A. Contact allergy to erythromycin. Contact Dermat 1996;34:428
  • Knutson DD, Swinyer LJ, Smoot WH. Meclocycline sulfosalicylate. Topical antibiotic agent for the treatment of acne vulgaris. Cutis 1981;27:203-4
  • De D, Dogra S, Kaur I. Dapsone induced acute photosensitivity dermatitis; a case report and review of literature. Lepr Rev 2007;78:401-4
  • Baptista A, Barros MA. Contact dermatitis from sodium fusidate. Contact Dermat 1990;23:186-7
  • Katsambas A, Graupe K, Stratigos J. Clinical studies of 20% azelaic acid cream in the treatment of acne vulgaris. Comparison with vehicle and topical tretinoin. Acta Derm Venereol 1989;143:35-9
  • Veraldi S, Micali G, Barbareschi M, et al. Topical nicotinamide in acne: a critical review. Eur J Acne 2012;3:21-6
  • Caputo R, Veraldi S. Drug-induced eczema. In: Marks R, Eczema. Martin Dunitz; London: 2002. p. 123-38

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.